Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer.
About 50-70% of patients with non-muscle invasive bladder cancer (NMIBC) experience relapse of disease. To establish a panel of protein biomarkers incorporated in a multiplexed microarray (BCa chip) and a classifier for diagnosing recurrent NMIBC. Urine samples from 45 patients were tested. Diagnostic performance was evaluated by receiver operating characteristic (ROC) analysis. A multi biomarker panel (ECadh, IL8, MMP9, EN2, VEGF, past recurrences, BCG therapies and stage at diagnosis) was identified yielding an area under the curve of 0.96. This biomarker panel represents a potential diagnostic tool for noninvasive diagnosis of recurrent NMIBC.